Blood progenitor cell separation from clinical leukapheresis product by magnetic nanoparticle binding and magnetophoresis

Ying Jing, Lee R. Moore, P. Stephen Williams, Jeffrey J. Chalmers, Sherif Farag, Brian Bolwell, Maciej Zborowski

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

Positive selection of CD34+ blood progenitor cells from circulation has been reported to improve patient recovery in applications of autologous transplantation. Current magnetic separation methods rely on cell capture and release on solid supports rather than sorting from flowing suspensions, which limits the range of therapeutic applications and the process scale up. We tested CD34+ cell immunomagnetic labeling and isolation from fresh leukocyte fraction of peripheral blood (leukapheresis) using the continuous quadrupole magnetic flow sorter (QMS), consisting of a flow channel (SHOT, Greenville, IN) and a quadrupole magnet with a maximum field intensity (Bo) of 1.42 T and a mean force field strength (Sm) of 1.45 x 108 TA/m 2. Both the sample magnetophoretic mobility (m) and the inlet and outlet flow patterns highly affect the QMS performance. Seven commercial progenitor cell labeling reagent combinations were quantitatively evaluated by measuring magnetophoretic mobility of a high CD34 expression cell line, KG-1a, using the cell tracking velocimeter (CTV). The CD34 Progenitor Cell Isolation Kit™ (Miltenyi Biotec, Bergisch Gladbach, Germany) showed the strongest labeling of KG-1a cells and was selected for progenitor cell enrichment from 11 fresh and 11 cryopreserved clinical leukapheresis samples derived from different donors. The CD34+ cells were isolated with a purity of 60-96%, a recovery of 18-60%, an enrichment rate of 12-169, and a throughput of (1.7-9.3) x 10 4 cells/s. The results also showed a highly regular dependence of the QMS performance on the flow conditions that agreed with the theoretical predictions based on the CD34+ cell magnetophoretic mobility.

Original languageEnglish (US)
Pages (from-to)1139-1154
Number of pages16
JournalBiotechnology and Bioengineering
Volume96
Issue number6
DOIs
StatePublished - Apr 15 2007
Externally publishedYes

Fingerprint

Leukapheresis
Cell Separation
Nanoparticles
Labeling
Blood Cells
Blood
Stem Cells
Velocimeters
Recovery
Magnetic separation
Channel flow
Sorting
Flow patterns
Magnets
Suspensions
Cells
Throughput
Cell Tracking
Autologous Transplantation
Germany

Keywords

  • Cell separation
  • Flow sorting
  • Immunomagnetic labeling
  • Leukapheresis
  • Magnetophoresis
  • Progenitor cell

ASJC Scopus subject areas

  • Biotechnology
  • Microbiology

Cite this

Blood progenitor cell separation from clinical leukapheresis product by magnetic nanoparticle binding and magnetophoresis. / Jing, Ying; Moore, Lee R.; Williams, P. Stephen; Chalmers, Jeffrey J.; Farag, Sherif; Bolwell, Brian; Zborowski, Maciej.

In: Biotechnology and Bioengineering, Vol. 96, No. 6, 15.04.2007, p. 1139-1154.

Research output: Contribution to journalArticle

Jing, Ying ; Moore, Lee R. ; Williams, P. Stephen ; Chalmers, Jeffrey J. ; Farag, Sherif ; Bolwell, Brian ; Zborowski, Maciej. / Blood progenitor cell separation from clinical leukapheresis product by magnetic nanoparticle binding and magnetophoresis. In: Biotechnology and Bioengineering. 2007 ; Vol. 96, No. 6. pp. 1139-1154.
@article{8a5e4c8fce0a4a3fb8caec834fac3dc6,
title = "Blood progenitor cell separation from clinical leukapheresis product by magnetic nanoparticle binding and magnetophoresis",
abstract = "Positive selection of CD34+ blood progenitor cells from circulation has been reported to improve patient recovery in applications of autologous transplantation. Current magnetic separation methods rely on cell capture and release on solid supports rather than sorting from flowing suspensions, which limits the range of therapeutic applications and the process scale up. We tested CD34+ cell immunomagnetic labeling and isolation from fresh leukocyte fraction of peripheral blood (leukapheresis) using the continuous quadrupole magnetic flow sorter (QMS), consisting of a flow channel (SHOT, Greenville, IN) and a quadrupole magnet with a maximum field intensity (Bo) of 1.42 T and a mean force field strength (Sm) of 1.45 x 108 TA/m 2. Both the sample magnetophoretic mobility (m) and the inlet and outlet flow patterns highly affect the QMS performance. Seven commercial progenitor cell labeling reagent combinations were quantitatively evaluated by measuring magnetophoretic mobility of a high CD34 expression cell line, KG-1a, using the cell tracking velocimeter (CTV). The CD34 Progenitor Cell Isolation Kit™ (Miltenyi Biotec, Bergisch Gladbach, Germany) showed the strongest labeling of KG-1a cells and was selected for progenitor cell enrichment from 11 fresh and 11 cryopreserved clinical leukapheresis samples derived from different donors. The CD34+ cells were isolated with a purity of 60-96{\%}, a recovery of 18-60{\%}, an enrichment rate of 12-169, and a throughput of (1.7-9.3) x 10 4 cells/s. The results also showed a highly regular dependence of the QMS performance on the flow conditions that agreed with the theoretical predictions based on the CD34+ cell magnetophoretic mobility.",
keywords = "Cell separation, Flow sorting, Immunomagnetic labeling, Leukapheresis, Magnetophoresis, Progenitor cell",
author = "Ying Jing and Moore, {Lee R.} and Williams, {P. Stephen} and Chalmers, {Jeffrey J.} and Sherif Farag and Brian Bolwell and Maciej Zborowski",
year = "2007",
month = "4",
day = "15",
doi = "10.1002/bit.21202",
language = "English (US)",
volume = "96",
pages = "1139--1154",
journal = "Biotechnology and Bioengineering",
issn = "0006-3592",
publisher = "Wiley-VCH Verlag",
number = "6",

}

TY - JOUR

T1 - Blood progenitor cell separation from clinical leukapheresis product by magnetic nanoparticle binding and magnetophoresis

AU - Jing, Ying

AU - Moore, Lee R.

AU - Williams, P. Stephen

AU - Chalmers, Jeffrey J.

AU - Farag, Sherif

AU - Bolwell, Brian

AU - Zborowski, Maciej

PY - 2007/4/15

Y1 - 2007/4/15

N2 - Positive selection of CD34+ blood progenitor cells from circulation has been reported to improve patient recovery in applications of autologous transplantation. Current magnetic separation methods rely on cell capture and release on solid supports rather than sorting from flowing suspensions, which limits the range of therapeutic applications and the process scale up. We tested CD34+ cell immunomagnetic labeling and isolation from fresh leukocyte fraction of peripheral blood (leukapheresis) using the continuous quadrupole magnetic flow sorter (QMS), consisting of a flow channel (SHOT, Greenville, IN) and a quadrupole magnet with a maximum field intensity (Bo) of 1.42 T and a mean force field strength (Sm) of 1.45 x 108 TA/m 2. Both the sample magnetophoretic mobility (m) and the inlet and outlet flow patterns highly affect the QMS performance. Seven commercial progenitor cell labeling reagent combinations were quantitatively evaluated by measuring magnetophoretic mobility of a high CD34 expression cell line, KG-1a, using the cell tracking velocimeter (CTV). The CD34 Progenitor Cell Isolation Kit™ (Miltenyi Biotec, Bergisch Gladbach, Germany) showed the strongest labeling of KG-1a cells and was selected for progenitor cell enrichment from 11 fresh and 11 cryopreserved clinical leukapheresis samples derived from different donors. The CD34+ cells were isolated with a purity of 60-96%, a recovery of 18-60%, an enrichment rate of 12-169, and a throughput of (1.7-9.3) x 10 4 cells/s. The results also showed a highly regular dependence of the QMS performance on the flow conditions that agreed with the theoretical predictions based on the CD34+ cell magnetophoretic mobility.

AB - Positive selection of CD34+ blood progenitor cells from circulation has been reported to improve patient recovery in applications of autologous transplantation. Current magnetic separation methods rely on cell capture and release on solid supports rather than sorting from flowing suspensions, which limits the range of therapeutic applications and the process scale up. We tested CD34+ cell immunomagnetic labeling and isolation from fresh leukocyte fraction of peripheral blood (leukapheresis) using the continuous quadrupole magnetic flow sorter (QMS), consisting of a flow channel (SHOT, Greenville, IN) and a quadrupole magnet with a maximum field intensity (Bo) of 1.42 T and a mean force field strength (Sm) of 1.45 x 108 TA/m 2. Both the sample magnetophoretic mobility (m) and the inlet and outlet flow patterns highly affect the QMS performance. Seven commercial progenitor cell labeling reagent combinations were quantitatively evaluated by measuring magnetophoretic mobility of a high CD34 expression cell line, KG-1a, using the cell tracking velocimeter (CTV). The CD34 Progenitor Cell Isolation Kit™ (Miltenyi Biotec, Bergisch Gladbach, Germany) showed the strongest labeling of KG-1a cells and was selected for progenitor cell enrichment from 11 fresh and 11 cryopreserved clinical leukapheresis samples derived from different donors. The CD34+ cells were isolated with a purity of 60-96%, a recovery of 18-60%, an enrichment rate of 12-169, and a throughput of (1.7-9.3) x 10 4 cells/s. The results also showed a highly regular dependence of the QMS performance on the flow conditions that agreed with the theoretical predictions based on the CD34+ cell magnetophoretic mobility.

KW - Cell separation

KW - Flow sorting

KW - Immunomagnetic labeling

KW - Leukapheresis

KW - Magnetophoresis

KW - Progenitor cell

UR - http://www.scopus.com/inward/record.url?scp=34247539952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247539952&partnerID=8YFLogxK

U2 - 10.1002/bit.21202

DO - 10.1002/bit.21202

M3 - Article

C2 - 17009321

AN - SCOPUS:34247539952

VL - 96

SP - 1139

EP - 1154

JO - Biotechnology and Bioengineering

JF - Biotechnology and Bioengineering

SN - 0006-3592

IS - 6

ER -